Meyer Pharmaceuticals Acquires NF-kappaB Decoy Technology For

Meyer Pharmaceuticals Acquires NF-kappaB Decoy Technology For
Medical News Today - Meyer Pharmaceuticals LLC announced that it has obtained a license for a new drug technology for the treatment of The first indication will be dermatitis or psoriasis. At the same time, pharmaceutical formulation of the decoy will be